Ligand Pharmaceuticals reported $301.83M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.2M 119.31M
Acorda Therapeutics ACOR:US $ 45.71M 71.06M
Agenus AGEN:US $ 73.54M 45.82M
Amgen AMGN:US $ 6630M 518M
Anika Therapeutics ANIK:US $ 97.18M 2.58M
Arena Pharmaceuticals ARNA:US $ 514.18M 81.2M
Arrowhead Research ARWR:US $ 325.98M 46.4M
Baxter International BAX:US $ 3136M 46M
Bristol Myers Squibb BMY:US $ 11024M 42M
Clovis Oncology CLVS:US $ 230.2M 39.28M
Dicerna Pharmaceuticals DRNA:US $ 221.21M 62.1M
Eli Lilly And LLY:US $ 3220M 217.6M
Enanta Pharmaceuticals ENTA:US $ 4.6M 72.53M
Endo International Ordinary Shares ENDP:US $ 1545.17M 117.4M
Flexion Therapeutics FLXN:US $ 107.63M 8.92M
Gilead Sciences GILD:US $ 7361M 3296M
GlaxoSmithKline GSK:LN 3503M 1254M
Glaxosmithkline GSK:US $ 3503M 1254M
Harsco HSC:US $ 77.87M 1.44M
Heron Therapeutics HRTX:US $ 191.17M 131.43M
Immunogen IMGN:US $ 239.54M 43.58M
Insmed INSM:US $ 928.33M 518.58M
Intrexon XON:US $ 36.41M 9.06M
Karyopharm Therapeutics KPTI:US $ 141.31M 52.84M
Lannett LCI:US $ 93.29M 12M
Ligand Pharmaceuticals LGND:US $ 301.83M 269.98M
Macrogenics MGNX:US $ 188.97M 29.53M
Pacira Pharmaceuticals PCRX:US $ 105.77M 39.08M
Rigel Pharmaceuticals RIGL:US $ 84.82M 64.78M
Sangamo Biosciences SGMO:US $ 169.88M 46.9M
Spectrum Pharmaceuticals SPPI:US $ 114.57M 45.05M
Teva Pharmaceutical Industries TEVA:US $ 2436M 693M
Veracyte VCYT:US $ 327.54M 3.48M